Discrimination of CD4+ T-helper, and CD8+ T-cytotoxic into their naïve and memory subpopulations revealed no significant differences between the average frequencies seen in AML and HD, although the AML patients did demonstrate greater heterogeneity (Additional file 3: Figures S9, S10). The gene discussed is CD8A; the disease is acute myeloid leukemia.